NanoViricides designs trial protocol for phase II...
Category : Clinical Trial Update 18 July 2025Overview NanoViricides, Inc, a publicly traded company and a clinical stage, leading global pione...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Baxdrostat meets primary & all secondary endpoints...
Category : Clinical Trial Update 18 July 2025Overview Positive high-level results from the BaxHTN phase III trial showed baxdrostat at two dos...
Anselamimab Misses Primary Endpoint in AstraZeneca...
Category : Clinical Trial Update 17 July 2025Overview High-level results from the Cardiac Amyloid Reaching for Extended Survival (CARES) phase...
Merck to initiate EXPrESSIVE phase 3 trials of MK-...
Category : Clinical Trial Update 17 July 2025Overview Merck, known as MSD outside of the United States and Canada, announced the initiation of...
Takeda announces positive results from two pivotal...
Category : Clinical Trial Update 17 July 2025Overview Takeda, a global company focused on creating better health for people and a brighter fut...
Latest Newsletter Post
-
Baxdrostat meets primary & all seco..
18 July 2025
-
NanoViricides designs trial protoco..
18 July 2025
-
Takeda announces positive results f..
17 July 2025
-
Merck to initiate EXPrESSIVE phase..
17 July 2025
-
Anselamimab Misses Primary Endpoint..
17 July 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com